Pharmaceutical trademarks in the European Union
Mary Spears, attorney at HGF, discusses the special considerations to be taken into account when applying for pharmaceutical trademarks within the EU
The pharmaceutical industry is an important sector in the European economy. It develops life-saving medicines, provides employment
to researchers and other skilled workers throughout the territory and generates billions of euros annually. As in other sectors,
manufacturers enjoy the protection provided by the patent regime and, both during the life of a patent and particularly after
its expiry, take advantage of the valuable tools trademarks offer for creating and maintaining demand for a product.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.